Product construction and laboratory application

The Retatrutide Pen contains 30 mg in a complete prefilled dosing pen. This peptide pen has an integrated click mechanism and does not require a separate powder-reconstitution step. The 30 mg format is intended for intensive laboratory screening and longitudinal cellular assays.

Research profile and composition

Retatrutide, also known as LY3437943, is a synthetic peptide with a triple-agonist profile targeting GLP-1, GIP and glucagon (GCGR) receptors. Scientific research models investigate receptor-binding kinetics, energy metabolism, glycaemic regulation, fatty acid oxidation and interactions between multiple metabolic signalling pathways.

Specifications and contents

Contents: one prefilled Retatrutide Pen, 30 mg
Integrated click mechanism
Nominal capacity: 300 clicks
Maximum mechanical setting: 60 clicks
Purity: ≥99.0% (HPLC)

Nominal click measurements

Clicks	Nominal retatrutide content
1	Approximately 0.1 mg
5	Approximately 0.5 mg
10	Approximately 1 mg
60	Approximately 6 mg
300	30 mg

These values describe nominal mechanical output and are not administration or dosing recommendations.

Quality and storage

HPLC-verified purity of ≥99.0%. Store the pen refrigerated at 2–8 °C, capped and protected from direct sunlight.

Frequently asked questions

Is this a complete pen?

Yes. You receive a complete prefilled dosing pen with an integrated click mechanism.

Does this peptide pen require reconstitution?

No. The supplied prefilled format does not require a separate peptide-powder reconstitution step.

Is the pen intended for human use?

No. The pen is supplied exclusively for laboratory and in-vitro research.

For laboratory research only

This product is supplied exclusively for laboratory, analytical and in-vitro research. It is not intended or approved for human or veterinary consumption, administration, diagnosis, therapeutic or cosmetic use. Keep out of reach of children and unauthorised persons.